Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02774759 · ClinicalTrials.gov registry record · NA

Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers

A NA study of Malignant Neoplasms of Female Genital Organs, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT02774759 is a NA study of Malignant Neoplasms of Female Genital Organs that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 15 participants, below the 41-participant average among 5 other Malignant Neoplasms of Female Genital Organs trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02774759, a NA study of Malignant Neoplasms of Female Genital Organs, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to learn if a home-based physical activity program is feasible and can help endometrial cancer survivors lose weight.

Conditions Studied

Malignant Neoplasms of Female Genital Organs

Interventions

  • BEHAVIORAL Resistance Training
  • BEHAVIORAL Questionnaires
  • DEVICE Accelerometer
  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Fitness Test

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2016-10-17
Est. Completion 2026-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02774759

The ClinicalTrials.gov registry entry for NCT02774759 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 41-participant average among 5 other Malignant Neoplasms of Female Genital Organs trials with a reported enrollment target (63% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignant Neoplasms of Female Genital Organs appearing as the primary indexed condition, and to 5 interventions - of which Resistance Training is the first listed.

NCT02774759 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02774759 about?

NCT02774759 is a clinical study titled "Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers". The goal of this research study is to learn if a home-based physical activity program is feasible and can help endometrial cancer survivors lose weight.

What is the current status of trial NCT02774759?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2016-10-17. Estimated completion is 2026-12-31.

What conditions does trial NCT02774759 study?

This clinical trial studies the following conditions: Malignant Neoplasms of Female Genital Organs.

What interventions are being tested in trial NCT02774759?

The interventions under investigation include: Resistance Training (BEHAVIORAL), Questionnaires (BEHAVIORAL), Accelerometer (DEVICE), Aerobic Exercise (BEHAVIORAL), Fitness Test (BEHAVIORAL).

Who is sponsoring clinical trial NCT02774759?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02774759 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Neoplasms of Female Genital Organs

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignant Neoplasms of Female Genital Organs

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.